A Multiplexed High Throughput Method to Evaluate Novel Nuclease Activity (in collaboration with Synthego)
Paragon Genomics targeted sequencing technology and Synthego’s expertise in CRISPR have been combined to develop a new method to evaluate novel nucleases that enables direct comparison of their editing activity. This white paper takes a closer look at this collaboration displaying the power of Synthego’s Halo™ Platform for Synthetic sgRNA and automation capabilities coupled with Paragon Genomics CleanPlex™ amplicon sequencing technology to have a side-by-side comparison of the activity of nucleases. Read the full white paper to see the data and discover the benefits of using the technology together for CRISPR QC.
Accurate Detection and Whole Genome Characterization of SARS-CoV-2 using CleanPlex® SARS-CoV-2 Research and Surveillance Panel
In this technical note, we demonstrate that the Paragon Genomics’ SARS-CoV-2 Panel with NGS sequencing can provide nucleic acid-level information for strain identification, inter and intra-host mutation analysis, phylogenetic analysis for surveillance and tracking, and ultimately advance vaccine development, thereby paving the way for our better understanding of this virus and helping the scientific community to fight this pandemic together. Read the full report and discover the benefits of using CleanPlex SARS-CoV-2 Panel for your COVID-19 research and surveillance projects.
A High-Performance Solution Combining CleanPlex® OncoZoom® Cancer Hotspot Panel and SOPHiA™ AI for Rapid Characterization of Somatic Mutations
In this technical note, experts from SOPHiA GENETICS compared CleanPlex to other target enrichment technologies and found CleanPlex to provide the highest coverage uniformity. Read the full report and discover the benefits of combining CleanPlex with SOPHiA AI for a complete genomics solution.
CleanPlex® Technology: Ultrafast, Simple, and Scalable Targeted Sequencing Solution for All Sequencing Platforms